13-12　ⓔ文献

  1. 鈴木　登，鈴木知美：再発性多発軟骨炎の診断と治療の現状．リウマチ科，2018; 59: 454–462.

  2. Arnaud L, Mathian A, et al: Pathogenesis of relapsing polychondritis: a 2013 update. Autoimmun Rev, 2014; 13: 90–95.

  3. Zeuner M, Straub RH, et al: Relapsing polychondritis: clinical and immunogenetic analysis of 62 patients. J Rheumatol, 1997; 24: 96–101.

  4. Foidart JM, Abe S, et al: Antibodies to type II collagen in relapsing polychondritis. N Eng J Med, 1978; 299: 1203–1207.

  5. Kempta Lekpa F, Piette JC, et al: Serum cartilage oligomeric matrix protein (COMP) level is a marker of disease activity in relapsing polychondritis. Clin Exp Rheumatol, 2010; 28: 553–555.

  6. Saxne T, Heinegard D: Serum concentrations of two cartilage matrix proteins reflecting different aspects of cartilage turnover in relapsing polychondritis. Arthritis Rheum, 1995; 38: 294–296.

  7. Cremer MA, Pitcock JA, et al: Auricular chondritis in rats. An experimental model of relapsing polychondritis induced with type II collagen. J Exp Med, 1981; 154: 535–540.

  8. Damiani JM, Levine HL: Relapsing polychondritis: report of ten cases. Laryngoscope, 1979; 89: 929–946.

  9. Cantarini L, Vitale A, et al: Diagnosis and classification of relapsing polychondritis. J Autoimmun, 2014; 48-49: 53–59.

  10. Hebbar M, Brouillard M, et al: Association of myelodysplastic syndrome and relapsing polychondritis: further evidence. Leukemia, 1995; 9: 731–733.

  11. Puechal X, Terrier B, et al: Relapsing polychondritis. Joint Bone Spine, 2014; 81: 118–124.

  12. Kemta Lekpa F, Kraus VB, et al: Biologics in relapsing polychondritis: a literature review. Semin Arthritis Rheum, 2012; 41: 712–719.

  13. Mathian A, Miyara M, et al: Relapsing polychondritis: A 2016 update on clinical features, diagnostic tools, treatment and biological drug use. Best Pract Res Clin Rheumatol, 2016; 30: 316–333.